Metoclopramide and Nuedexta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metoclopramide and Nuedexta. Common interactions include alopecia among females and urinary tract infection among males.

The phase IV clinical study analyzes what interactions people who take Metoclopramide and Nuedexta have. It is created by eHealthMe based on reports of 6 people who take Metoclopramide and Nuedexta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

6 people who take Metoclopramide and Nuedexta together, and have interactions are studied.


What is Metoclopramide?

Metoclopramide has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 71,220 Metoclopramide users for its effectiveness, alternative drugs and more.

What is Nuedexta?

Nuedexta has active ingredients of dextromethorphan hydrobromide; quinidine sulfate. eHealthMe is studying from 3,366 Nuedexta users for its effectiveness, alternative drugs and more.

Number of Metoclopramide and Nuedexta reports submitted per year:

Metoclopramide and Nuedexta drug interactions.

Common Metoclopramide and Nuedexta drug interactions by gender *:

female:

  1. Alopecia
  2. Disturbance in attention
  3. Eye movement disorder
  4. Gait disturbance
  5. Headache
  6. Hypoaesthesia
  7. Memory impairment
  8. Multiple sclerosis relapse
  9. Musculoskeletal chest pain
  10. Pain

male:

  1. Urinary tract infection

Common Metoclopramide and Nuedexta drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Alopecia
  2. Eye movement disorder
  3. Gait disturbance
  4. Headache
  5. Hypoaesthesia
  6. Memory impairment
  7. Multiple sclerosis relapse
  8. Musculoskeletal chest pain
  9. Pain
  10. Paraesthesia

50-59:

n/a

60+:

  1. Diarrhoea

* Approximation only. Some reports may have incomplete information.

Do you take Metoclopramide and Nuedexta?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Metoclopramide and Nuedexta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Metoclopramide side effects:

Browse all side effects of Metoclopramide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nuedexta side effects:

Browse all side effects of Nuedexta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Metoclopramide interactions:

Browse all interactions between Metoclopramide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nuedexta interactions:

Browse all interactions between Nuedexta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride and dextromethorphan hydrobromide; quinidine sulfate (the active ingredients of Metoclopramide and Nuedexta, respectively), and Metoclopramide and Nuedexta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Metoclopramide and Nuedexta.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: